This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Broutet N et al. (2003) Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 17: 99–109
Prouzet-Mauléon V et al. (2005) Pathogen evolution in vivo: genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain. J Clin Microbiol 43: 4237–4241
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mégraud, F., Lamouliatte, H. Helicobacter pylori infection relapse after eradication is not a problem in developed countries. Nat Rev Gastroenterol Hepatol 3, 484–485 (2006). https://doi.org/10.1038/ncpgasthep0600
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0600